{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["In Vitro", "In Vivo", "Pyrus biossieriana", "Toxoplasma gondii", "Arbutin"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38231312", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "30"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s11686-023-00759-x"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "17"}], "Journal": {"ISSN": "1896-1851", "JournalIssue": {"Volume": "69", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Acta parasitologica", "ISOAbbreviation": "Acta Parasitol"}, "ArticleTitle": "Anti-Toxoplasma In Vitro and In Vivo Activity of Pyrus boissieriana Arbutin-Rich Fraction.", "Pagination": {"StartPage": "567", "EndPage": "573", "MedlinePgn": "567-573"}, "Abstract": {"AbstractText": ["Pyrus boissieriana is a rich source of arbutin and has been used in herbal medicine to treat infectious diseases. This study aimed to investigate the effect of the arbutin-rich fraction of Pyrus boissieriana aerial parts on Toxoplasma gondii In Vitro and In Vivo.", "An arbutin-rich fraction of P. boissieriana was prepared beforehand. Flow cytometry was used to evaluate the effect of different concentrations (1-512\u00a0\u00b5g/ml) of the P. boissieriana arbutin-rich fraction on Toxoplasma tachyzoites (RH strain). The cytotoxicity of the concentrations on the macrophage J774 cell line was also investigated by MTT assay. For In Vivo investigation, 4-6-week-old female mice infected with the RH strain of T. gondii were treated with different doses (16, 32, 64, 256, and 512\u00a0mg/kg) of the fraction using gavage.", "The highest and lowest lethality of the tachyzoites were 89.6% and 25.9% related to the concentrations of 512\u00a0\u00b5g/ml and 1\u00a0\u00b5g/ml, respectively, with an IC<sub>50</sub> value of 18.1\u00a0\u00b5g/ml\u2009\u00b1\u20090.37. The cytotoxicity test showed an IC<sub>50</sub> value of 984.3\u00a0\u00b5g/ml\u2009\u00b1\u20090.76 after 48\u00a0h incubation. The mean survival of mice at the lowest treated dose (16\u00a0mg/kg) was 6.6\u00a0days, and it was 15\u00a0days at the highest dose (512\u00a0mg/kg). The concentrations of 512, 256, 128, and 64\u00a0mg/kg of the fraction compared to the negative control (6.2\u00a0days mean survival) significantly increased the survival time of mice (P\u2009<\u20090.001, P\u2009=\u20090.009, P\u2009=\u20090.018, and P\u2009=\u20090.021, respectively).", "The results showed that the arbutin-rich fraction of P. boissieriana is effective against T. gondii In Vitro and In Vivo and may be a reliable alternative to conventional treatment for toxoplasmosis, although further studies are necessary."], "CopyrightInformation": "\u00a9 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Valfajr Health Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Bahreini", "ForeName": "Mohammad Saleh", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Pourmohammadi", "ForeName": "Seyyed Farzad", "Initials": "SF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Gholami", "ForeName": "Meysam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Habibollahi", "ForeName": "Mojtaba", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Pasdaran", "ForeName": "Ardalan", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Hamedi", "ForeName": "Azadeh", "Initials": "A"}, {"Identifier": ["0000-0002-7945-2370"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. asgarig@sums.ac.ir."}], "LastName": "Asgari", "ForeName": "Qasem", "Initials": "Q"}], "GrantList": [{"GrantID": "21764", "Agency": "Vice-Chancellor for Research, Shiraz University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Acta Parasitol", "NlmUniqueID": "9301947", "ISSNLinking": "1230-2821"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "C5INA23HXF", "NameOfSubstance": "Arbutin"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiprotozoal Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Toxoplasma"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Arbutin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiprotozoal Agents"}, {"QualifierName": ["parasitology", "drug effects"], "DescriptorName": "Macrophages"}, {"QualifierName": ["drug therapy", "parasitology"], "DescriptorName": "Toxoplasmosis, Animal"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug therapy", "parasitology"], "DescriptorName": "Toxoplasmosis"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bahreini MS, Zarei F, Dastan N, Sami Jahromi S, Pourzargham P, Asgari Q (2020) The relationship between Toxoplasma gondii infection in mothers and neonate\u2019s gender. J Matern Fetal Neonatal Med 35(22):4263\u20134267. https://doi.org/10.1080/14767058.2020.1849103", "ArticleIdList": ["10.1080/14767058.2020.1849103", "33207997"]}, {"Citation": "Omidian M, Asgari Q, Bahreini MS, Moshki S, Sedaghat B, Adnani Sadati SJ (2022) Acute toxoplasmosis can increase serum dopamine level. J Parasit Dis 46(2):337\u2013342. https://doi.org/10.1007/s12639-021-01447-1", "ArticleIdList": ["10.1007/s12639-021-01447-1", "35692467"]}, {"Citation": "Dubey JP (2008) The history of Toxoplasma gondii\u2014the first 100 years. J Eukaryot Microbiol 55(6):467\u2013475. https://doi.org/10.1111/j.1550-7408.2008.00345.x", "ArticleIdList": ["10.1111/j.1550-7408.2008.00345.x", "19120791"]}, {"Citation": "Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG (2018) Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev 31(4):e00057-e117. https://doi.org/10.1128/cmr.00057-17", "ArticleIdList": ["10.1128/cmr.00057-17", "30209035", "6148195"]}, {"Citation": "Ghanadian M, Khamesipour F, Hejazi SH, Razavi SM, Sadraei H, Namdar F (2022) In Vitro and In Vivo anti-toxoplasma activities of Dracocephalum kotschyi extract in experimental models of acute toxoplasmosis. Acta Parasitol 67(1):487\u2013495. https://doi.org/10.1007/s11686-021-00491-4", "ArticleIdList": ["10.1007/s11686-021-00491-4", "34800216"]}, {"Citation": "Asgari Q, Mikaali F, Ahmadi B, Bahraini MS (2019) In Vitro and In Vivo study of the effects of Lawsonia inermis on Toxoplasma gondii. Armaghane danesh 24(1):31\u201342. https://doi.org/10.52547/armaghanj.24.1.31", "ArticleIdList": ["10.52547/armaghanj.24.1.31"]}, {"Citation": "Cheraghipour K, Masoori L, Ezzatpour B, Roozbehani M, Sheikhian A, Malekara V, Niazi M, Mardanshah O, Moradpour K, Mahmoudvand H (2021) The experimental role of medicinal plants in treatment of Toxoplasma gondii infection: a systematic review. Acta Parasitol 66(2):303\u2013328. https://doi.org/10.1007/s11686-020-00300-4", "ArticleIdList": ["10.1007/s11686-020-00300-4", "33159263"]}, {"Citation": "Azadbakht M, Ramzani M (2003) Identification and determination of phenyl glycoside in the leaf of Pyrus boissieriana buhse by two methods of HPLC and spectrophotometery. J Maz Univ Med Sci 13(41):1\u20138"}, {"Citation": "Browicz K (1993) Conspect and chorology of the genus Pyrus L. Arboretum K\u00f3rnickie 38:17\u201333"}, {"Citation": "Petricic J, Apostolski R, Srepel B (1981) The leaf of the wild pear-tree as an Arbutinic herb"}, {"Citation": "Couteau C, Coiffard LJ (2000) Photostability determination of arbutin, a vegetable whitening agent. II. Farmaco 55(5):410\u2013413. https://doi.org/10.1016/S0014-827X(00)00049-5", "ArticleIdList": ["10.1016/S0014-827X(00)00049-5", "10983289"]}, {"Citation": "Stambergova A, Supcikova M, Leifetova I (1985) Evaluation of phenolic substances in Arctostaphylos uva ursi, determination of arbutin, methylarbutin and hydroquinone in the leaves by HPLC, pp 179\u2013182"}, {"Citation": "Nabeel Yehya N (2014) Identification of some cultivars of Pyrus communis L. planted in Mosul city using morpholgical and chemical characters. Coll Basic Educ Res J 13(2):953\u2013976"}, {"Citation": "G\u00fcven K, Y\u00fccel E, Cetinta\u015f F (2006) Antimicrobial activities of fruits of Crataegus. and Pyrus. species. Pharm Biol 44(2):79\u201383. https://doi.org/10.1080/13880200600591253", "ArticleIdList": ["10.1080/13880200600591253"]}, {"Citation": "Elahimanesh F, Hassanzadeh D, Sayfzadeh N, Abdolmohammadi J, Abdolmohammadi J (2015) The effects of Pyrus Biossieriana Bushe leaf extract on the. S J Nurs Midwifery Paramed Fac 1(1):48\u201355. https://doi.org/10.29252/sjnmp.1.1.48", "ArticleIdList": ["10.29252/sjnmp.1.1.48"]}, {"Citation": "Nabavi SM, Ebrahimzadeh MA, Nabavi SF, Fazelian M, Eslami B (2009) In Vitro antioxidant and free radical scavenging activity of Diospyros lotus and Pyrus boissieriana growing in Iran. Pharmacog Mag 5(18):122\u2013126"}, {"Citation": "Alam P, Alqasoumi S, Shakeel F, Abdel-Kader M (2011) HPTLC densitometric analysis of arbutin in bulk drug and methanolic extracts of Arctostaphylos uva-ursi. Nat Prod Res 25(17):1671\u20131675. https://doi.org/10.1080/14786419.2010.529447", "ArticleIdList": ["10.1080/14786419.2010.529447", "21331974"]}, {"Citation": "Bahreini MS, Iraji A, Edraki N, Arab Monfared A, Asgari Q (2022) Synthesis and anti-Toxoplasma activity of indole-triazole compounds on tachyzoites of RH strain. Ann Med Surg 74:103245. https://doi.org/10.1016/j.amsu.2022.103245", "ArticleIdList": ["10.1016/j.amsu.2022.103245"]}, {"Citation": "Bahreini MS, Yazdi AR, Jowkar F, Motamedi M, Mikaeili F (2022) Cytotoxic screening and In Vitro effect of sodium chlorite against Leishmania major promastigotes. J Parasit Dis 46(4):945\u2013951. https://doi.org/10.1007/s12639-022-01511-4", "ArticleIdList": ["10.1007/s12639-022-01511-4", "36457781", "9606154"]}, {"Citation": "Bilia A, Rubio MD, Alvarez ML, Morelli I, Gonzalez JM (1994) New benzyl alcohol glycosides from Pyrus bourgaeana. Planta Med 60(06):569\u2013571. https://doi.org/10.1055/s-2006-959574", "ArticleIdList": ["10.1055/s-2006-959574", "7809215"]}, {"Citation": "Azadbakht M, Ramezani M, Marston A, Hostettmann K, Jahromi Moghaddam M (2004) Biological activity of leaf extract and phenolglycoside arbutin of pyrus boissieriana buhse. J Med Plant 3(10):9\u201314"}, {"Citation": "Jin S, Sato N (2003) Benzoquinone, the substance essential for antibacterial activity in aqueous extracts from succulent young shoots of the pear Pyrus spp. Phytochemistry 62(1):101\u2013107. https://doi.org/10.1016/S0031-9422(02)00444-2", "ArticleIdList": ["10.1016/S0031-9422(02)00444-2", "12475625"]}, {"Citation": "Migas P, Krauze-Baranowska M (2015) The significance of arbutin and its derivatives in therapy and cosmetics. Phytochem Lett 13:35\u201340. https://doi.org/10.1016/j.phytol.2015.05.015", "ArticleIdList": ["10.1016/j.phytol.2015.05.015"]}, {"Citation": "Busetto GM, Giovannone R, Ferro M, Tricarico S, Del Giudice F, Matei DV, De Cobelli O, Gentile V, De Berardinis E (2014) Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox<sup>\u00ae</sup>) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens<sup>\u00ae</sup>). BMC Urol 14(1):1\u20139. https://doi.org/10.1186/1471-2490-14-53", "ArticleIdList": ["10.1186/1471-2490-14-53"]}, {"Citation": "Zhao W, Wang S, Qin T, Wang W (2019) Arbutin attenuates hydrogen peroxide-induced oxidative injury through regulation of microRNA-29a in retinal ganglion cells. Biomed Pharmacother 112:108729\u2013108729. https://doi.org/10.1016/j.biopha.2019.108729", "ArticleIdList": ["10.1016/j.biopha.2019.108729", "30970524"]}, {"Citation": "Adeyemi OS, Atolani O, Awakan OJ, Olaolu TD, Nwonuma CO, Alejolowo O, Otohinoyi DA, Rotimi D, Owolabi A, Batiha GE (2019) In Vitro screening to identify anti-Toxoplasma compounds and in silico modeling for bioactivities and toxicity. Yale J Biol Med 92(3):369\u2013383", "ArticleIdList": ["31543702", "6747942"]}, {"Citation": "Jin YH, Lee SJ, Chung MH, Park JH, Park YI, Cho TH, Lee SK (1999) Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism. Arch Pharm Res 22(3):232. https://doi.org/10.1007/BF02976355", "ArticleIdList": ["10.1007/BF02976355", "10403123"]}, {"Citation": "Bekier A, W\u0119gli\u0144ska L, Paneth A, Paneth P, Dzitko K (2021) 4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents. J Enzyme Inhib Med Chem 36(1):1145\u20131164. https://doi.org/10.1080/14756366.2021.1931164", "ArticleIdList": ["10.1080/14756366.2021.1931164", "34074198", "8174488"]}]}], "History": [{"Year": "2022", "Month": "8", "Day": "19"}, {"Year": "2023", "Month": "11", "Day": "20"}, {"Year": "2024", "Month": "4", "Day": "30", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "1", "Day": "17", "Hour": "12", "Minute": "44"}, {"Year": "2024", "Month": "1", "Day": "17", "Hour": "11", "Minute": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38231312", "10.1007/s11686-023-00759-x", "10.1007/s11686-023-00759-x"]}}]}